Purified the Hemorrhagic Toxin of <em>Agkistrodon acutus</em> Venom and Its Antibody Applied in Identification Different Venoms

China Biotechnology

2013, Vol. 33

Issue (3): 123-129 DOI:

Purified the Hemorrhagic Toxin of Agkistrodon acutus Venom and Its Antibody Applied in Identification Different Venoms

ZHENG Ying, ZHANG Yi, YE Feng-ping, Nie Xue-feng, ZHANG Zhi-xiao, Qiu Wei, FAN Quan-shui

Military Medical Institute,CDC of PLA Chengdu Military Area Command,Kunming 650118,China

Download:

HTML

PDF(645KB) HTML
Export: BibTeX | EndNote (RIS)

Abstract Aim: To purify the hemorrhagic toxin (HR) of Agkistrodon acutus venom, prepare its special antibody and establish related ELISA method for detection of different snake venoms. Methods: HR was obtained from Agkistrodon acutus venom by several column chromatographs and used as antigen to immunized rabbits. IgG antibody was isolated and purified from immunized rabbit plasma by ammonium sulfate precipitate and affinity chromatography, labeled with HRP. The five venoms from Viperidae were identified by developed ELISA using purified specific igG antibody. Results: The purity of purified HR was up to 99.49 %, ELISA analysis suggested that the specific HRP-IgG antibody can be fast and exactly identified venom of Agkistrodon acutus from other viperidae venoms, and its sensitivity was 10ng/ml, the rate of cross reaction was <15%. Conclusion: The developed method of purified HR antibody sandwich ELISA can be quickly and accurately identified venom of Agkistrodon acutus from other kinds of viperidae venoms.

Key words： Agkistrodon acutus Hemorrhagic toxin Isolation Antibody

Received: 26 November 2012 Published: 25 March 2013

ZTFLH:

Q814

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHENG Ying
	ZHANG Yi
	YE Feng-ping
	Nie Xue-feng
	ZHANG Zhi-xiao
	Qiu Wei
	FAN Quan-shui

Cite this article:

ZHENG Ying, ZHANG Yi, YE Feng-ping, Nie Xue-feng, ZHANG Zhi-xiao, Qiu Wei, FAN Quan-shui. Purified the Hemorrhagic Toxin of Agkistrodon acutus Venom and Its Antibody Applied in Identification Different Venoms. China Biotechnology, 2013, 33(3): 123-129.

URL:

https://manu60.magtech.com.cn/biotech/ OR https://manu60.magtech.com.cn/biotech/Y2013/V33/I3/123

[1] 张庶民,抗蛇毒血清、抗狂犬病病毒血清国际会议纪要. 中国生物制品学杂志, 2007, 20(6):471-472. Zhang S M.Notes of antivenin and antirabies serum internationalconferences.Chin J Biologicals, 2007, 20(6): 471-472.
[2] Chippaux J P. Snake-bites: appraisal of the global situation. Bull World Health Organ, 1998, 76(5): 515-524.
[3] Rojas, G, Bogarin G, Gutierrez, J M. Snakebite mortality in Costa Rica. Toxicon, 1997, 35(11): 1639-1643.
[4] Theakston R D, Warrell D A, Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon, 2003, 41(5): 541-557.
[5] Dart R C, McNally J. Efficacy safety and use of snake antivenoms in the United States. Ann Emerg Med, 2001, 37(2): 181-188.
[6] Warrell D A. Clinical toxicology of snakebite in Asia. In: Meier J, White J, editors. Handbook of clinical toxicology of animal venoms and poisons. Boca Raton, Florida: CRC Press, 1995, 493-594.
[7] Songsumard S. Snakebite in thailand, in: annual epidemiological surveillance report, Ministry of Public Health, 1995, 324-333.
[8] Viravan C, Veeravat U, Warrell M J, et al. ELISA confirmation of acute and past envenoming by the monocellate Thai cobra (Naja kaouthia) . Am J Trop Med Hyg, 1986, 35(1): 173-181.
[9] 蓝海,陈远聪.中国毒蛇及蛇伤救治.上海:上海科学技术出版社,2008,21-22. Lan H, Chen Y C. Snakes and Treatment of Poisonous Snakebites of China. Shanghai: Shanghai Science and Technology Press, 2008, 21-22.
[10] 李艳霞, 刘仲明, 张水华. 蛇伤检测技术的研究进展. 实用医学杂志, 2005, 2(18): 2093-2094 Li Y X, Liu Z M, Zhang S H. Research progress of detection technology in snakebite.The Journal of Practical Medicine, 2005, 2(18): 2093-2094.
[11] 张绎,郑颖,范泉水. 蛇伤检测方法的研究进展. 现代检验医学杂志, 2008, 23(5): 114-116. Zhang Y, Zheng Y, Fan Q S. Research progress of detection method in snakebite.J Mod Lab Med, 2008, 23(5): 114-116.
[12] 国家药典委员会. 蛇毒血清. 2010年版《中华人民共和国药典》三部, 北京:中国医药科技出版社,2010, 194-208. ChPC. Ch P, VolⅢ, 2010. Beijing: The Medicine Science and Technology Press of China, 2010: 194-208.
[13] 奥斯伯F.M, 金斯顿 RE, 赛德曼 JG, 等. 精编分子生物学实验指南. 第四版. 北京: 科学出版社, 2005: 475 - 479. Ausubel F M, Kingston R E, Seidman J G, et al. Short Protocols in Molecular Biology. 4^th ed. Beijing: Science Press, 2005: 475-479.
[14] 周海钧.药品生物检定.北京:人民卫生出版社,2005:146-151. Zhou H J. Biological Standardization of Drug Product. Beijing: People’s Medical Publishing House, 2005:146-151.
[15] 徐叔云,卞如濂,陈修.药理实验方法学.第三版.北京:人民卫生出版社,2006: 179-187. Xu S Y, Bian R L, Chen X. Methodology of Pharmacology Experiments. 3^th ed, Beijing: People’s Medical Publishing House, 2006:179-187.
[16] WS1-XG—031-2000, 国家药品监督管理局降纤酶国家药品标准.WS1-XG—031-2000. State Food and Drug Administration, The drug quality standard of Defibrase. WS1-XG—031-2000.
[17] 国家药典委员会. 2010年版《中华人民共和国药典》三部. 北京:中国医药科技出版社,2010, 附录34. ChPC. Ch P, VolⅢ, 2010. Beijing: The Medicine Science and Technology Press of China, 2010, appendix 34.
[18] F.奥斯伯,R.布伦特,R.E.金斯顿等.精编分子生物学实验指南.第三版.北京:科学出版社.1998.413-419. Ausubel F M, Brent R, Kingston R E. Short Protocols in Molecular Biology. 3^th ed. Beijing: Science Press, 1998, 413-419.
[19] 萨姆布鲁克J, 弗里奇EF, 曼尼阿蒂斯T. 分子克隆实验指南. 第二版. 北京: 科学出版社, 1996: 880 - 887. Sambrook. J, Russell D W. Molecular Cloning: A Laboratory Manual. 2^nd ed, Beijing: Science Press, 1996: 880-887.
[20] 余培南,钟汉,余永州,等.中国蛇伤学.太原:陕西出版集团陕西科技出版社,2009, 32. Yu P N, Zhong H, Yu Y Z, et al. Therapeutics and Epidemiology of Snakebites. Taiyuan:Shanxi Science & Technology Press,PublishingGroup in Shanxi, 2009, 32.
[21] 赵尔宓.中国蛇类.合肥:安徽科学技术出版社,2006,3-4. Zhao E M. Snakes of China. Hefei: Anhui Science and Technology Publishing House, 2006, 3-4.
[22] 张志晓,郑颖,杨彦,等. 尖吻蝮蛇蛇毒金属蛋白酶cDNA 序列抗原位点分析及免疫保护效果观察, 第二军医大学学报,2010, 31(4):364-368. Zhang Z X, Zheng Y, Yang Y, et al. Epitope analysis of cDNA sequences of Deinagkistrodonacutus snake venom metalloproteinases and observation of their immune protective effects. Academic Journal of Second Military Medical University, 2010, 31(4):364-368.
[23] Coulter AR, Harris RD, Sutherland SK et a1. Clinical laboratory:enzyme inmmnoassay for the rapid clinical identification of snake venom.Med J Aust. 1980, 1(9):433-436.
[24] 郑颖,范泉水,张连江,等.我国主要致伤的9种陆生毒蛇抗血清间的交叉免疫中和效价测定.第八届中国生物毒素学术研讨会论文摘要集 , 2007. Zheng Y, Fan Q S, Zhang L J,et al. Determining the cross immunity titer of 9 antivenenes in Chinese.8th Chinese Congress on Biological Toxins, Nanning, 2007.

[1]	CHEN Xiu-yue,ZHOU Wen-feng,HE Qing,SU Bing,ZOU Ya-wen. Preparation, Purification and Identification of Bacteriophage Qβ Virus-like Particles[J]. China Biotechnology, 2021, 41(7): 42-49.

[2]	CHEN Wen-jie,MIAO Xian-feng. Domestic Research and Development Status of Antibody-drug Conjugates and Strategic Layout of Key Enterprises[J]. China Biotechnology, 2021, 41(6): 105-110.

[3]	XU Ye-chun,LIU Hong,LI Jian-feng,SHEN Jing-shan,JIANG Hua-liang. Recent Progress in Drug Development against COVID-19[J]. China Biotechnology, 2021, 41(6): 111-118.

[4]	YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.

[5]	MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.

[6]	QIU Jin-ge,LIU De-wu,SUN Bao-li,LI Yao-kun,GUO Yong-qing,DENG Ming,LIU Guang-bin. Research Progress on Animal Exosome Isolation Methods[J]. China Biotechnology, 2020, 40(9): 36-42.

[7]	ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.

[8]	YANG Xiao-ying,LI Meng,ZHAO Wei,TANG Min,ZHANG Zhi-qian. Preparation and Preliminary Characterization of Anti-α2δ1/CD3 Bispecific Antibody[J]. China Biotechnology, 2020, 40(7): 9-14.

[9]	WU Rui-jun,LI Zhi-fei,ZHANG Xin,PU Run,AO Yi,SUN Yan-rong. Development and Prospect of Antibody Drugs for SARS-CoV-2[J]. China Biotechnology, 2020, 40(5): 1-6.

[10]	WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. *Accurate Detection of Streptococcus pneumoniae* by Using Ribosomal Protein L7 / L12 as Molecular Marker**[J]. China Biotechnology, 2020, 40(4): 34-41.

[11]	YANG Li,SHI Xiao-yu,LI Wen-lei,LI Jian,XU Han-mei. Optimization of Electroporation Conditions in Construction of Phage Display Antibody Library[J]. China Biotechnology, 2020, 40(4): 42-48.

[12]	LI Tong-tong,SONG Cai-ling,YANG Kai-yue,WANG Wen-jing,CHEN Hui-yu,LIU Ming. Preparation and Neutralization Activity of Anti-Canine Parvovirus VP2 Protein Single-chain Antibody[J]. China Biotechnology, 2020, 40(4): 10-16.

[13]	CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein[J]. China Biotechnology, 2020, 40(3): 31-37.

[14]	LI Dong-qiao,LV Lu-cheng,YANG Yan-ping. The Research Status and Development Trend of Global Human Coronavirus Antibody Field[J]. China Biotechnology, 2020, 40(1-2): 65-70.

[15]	KONG Jian-tao,ZHUANG Ying-ping,GUO Mei-jin. Enhancement of Anti-CD20 Monoclonal Antibody Expression by CHO based on DOE and Amino Acid Supplemental Strategy[J]. China Biotechnology, 2020, 40(12): 41-48.

Viewed

Full text

Abstract

Cited

Shared

Discussed